PTH · Invesco Dorsey Wright Healthcare Momentum ETF
Invesco Exchange-Traded Fund Trust
$58.84
+3.45%
At close · Oct 20
Net assets $235,211,770
Holdings57
1 month
-5.74%
Year to date
+18.39%
52-week range
$45.83–$64.10
30-session avg volume
38,974
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000013104
- Report date
- Jul 31, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings59.33%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC100.04%
STIV27.70%
Country allocation
US116.14%
BM4.95%
IE3.02%
VG1.51%
NL1.50%
JE0.62%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Invesco Private Prime Fund | $48,911,773 | 20.79% | |
| Invesco Private Government Fund | $16,076,714 | 6.83% | |
| Guardant Health, Inc. | GH | $11,695,516 | 4.97% |
| Roivant Sciences Ltd. | ROIV | $11,631,774 | 4.95% |
| Revolution Medicines, Inc. | RVMD | $11,613,170 | 4.94% |
| Axsome Therapeutics, Inc. | AXSM | $9,698,375 | 4.12% |
| BrightSpring Health Services, Inc. | BTSG | $9,475,738 | 4.03% |
| Liquidia Corp. | LQDA | $7,084,922 | 3.01% |
| Erasca, Inc. | ERAS | $6,915,495 | 2.94% |
| Oruka Therapeutics, Inc. | ORKA | $6,438,761 | 2.74% |
| 10x Genomics, Inc. | TXG | $5,340,754 | 2.27% |
| Relay Therapeutics, Inc. | RLAY | $5,286,673 | 2.25% |
| Tango Therapeutics Inc. | TNGX | $5,074,669 | 2.16% |
| Travere Therapeutics, Inc. | TVTX | $5,071,570 | 2.16% |
| Oscar Health, Inc. | OSCR | $4,934,571 | 2.10% |
| Illumina, Inc. | ILMN | $4,894,301 | 2.08% |
| agilon health, Inc. | AGL | $4,857,803 | 2.07% |
| Axogen, Inc. | AXGN | $4,841,149 | 2.06% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | $4,738,538 | 2.01% |
| Spyre Therapeutics, Inc. | SYRE | $4,732,328 | 2.01% |
| Replimune Group, Inc. | REPL | $4,536,538 | 1.93% |
| Jazz Pharmaceuticals PLC | JAZZ | $4,532,516 | 1.93% |
| Moderna, Inc. | MRNA | $4,459,881 | 1.90% |
| Cytokinetics, Inc. | CYTK | $4,440,220 | 1.89% |
| Viatris Inc. | VTRS | $4,282,164 | 1.82% |
| Centene Corp. | CNC | $4,203,894 | 1.79% |
| Humana Inc. | HUM | $4,160,375 | 1.77% |
| Ligand Pharmaceuticals Inc. | LGND | $4,096,582 | 1.74% |
| Corcept Therapeutics Inc. | CORT | $4,032,910 | 1.71% |
| Enliven Therapeutics, Inc. | ELVN | $3,994,772 | 1.70% |
| Twist Bioscience Corp. | TWST | $3,740,733 | 1.59% |
| Hims & Hers Health, Inc. | HIMS | $3,699,436 | 1.57% |
| MBX Biosciences, Inc. | MBX | $3,602,811 | 1.53% |
| Arcutis Biotherapeutics, Inc. | ARQT | $3,589,302 | 1.53% |
| Establishment Labs Holdings Inc. | ESTA | $3,554,461 | 1.51% |
| uniQure N.V. | QURE | $3,535,208 | 1.50% |
| PACS Group, Inc. | PACS | $3,131,073 | 1.33% |
| Exelixis, Inc. | EXEL | $3,092,232 | 1.31% |
| Trevi Therapeutics, Inc. | TRVI | $2,749,892 | 1.17% |
| Krystal Biotech, Inc. | KRYS | $2,747,722 | 1.17% |
| National HealthCare Corp. | NHC | $2,629,859 | 1.12% |
| Amneal Pharmaceuticals, Inc. | AMRX | $2,626,190 | 1.12% |
| Alkermes PLC | ALKS | $2,580,891 | 1.10% |
| Veracyte, Inc. | VCYT | $2,556,169 | 1.09% |
| NeoGenomics, Inc. | NEO | $2,531,657 | 1.08% |
| Nuvation Bio Inc. | NUVB | $2,499,521 | 1.06% |
| TG Therapeutics, Inc. | TGTX | $2,482,195 | 1.06% |
| AbSci Corp. | ABSI | $2,337,882 | 0.99% |
| Denali Therapeutics Inc. | DNLI | $2,286,139 | 0.97% |
| Disc Medicine, Inc. | IRON | $2,094,554 | 0.89% |
Showing the top 50 of 57 holdings. Create a free account to see every holding and download the CSV.